The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin:Comparing With Standardized Statin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

Also called NCT02726555

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Wenzhou Medical University (from the registry)
Registry
  • NCT NCT02726555
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02726555. Randomized; double masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2026-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin:Comparing With Standardized Statin
Condition
Dyslipidemia
Condition
Atherosclerosis
Intervention (Drug)
Red yeast rice and atorvastatin
Intervention (Drug)
Atorvastatin alone
Lead sponsor
Wenzhou Medical University (class: other)

Record details

Record id
cardio:ct-nct02726555
Content hash
57c73ecdece890837732c49aefea4cf687cd4c7e485ebc891a31d79c1eff6451